chr8-142876677-C-G
Variant summary
Our verdict is Uncertain significance. The variant received 3 ACMG points: 3P and 0B. PP3_ModeratePP5
The NM_000497.4(CYP11B1):c.799+5G>C variant causes a splice region, intron change. The variant allele was found at a frequency of 0.000028 in 1,606,900 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 2/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_000497.4 splice_region, intron
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 3 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| CYP11B1 | NM_000497.4 | c.799+5G>C | splice_region_variant, intron_variant | Intron 4 of 8 | ENST00000292427.10 | NP_000488.3 | ||
| CYP11B1 | NM_001026213.1 | c.799+5G>C | splice_region_variant, intron_variant | Intron 4 of 7 | NP_001021384.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000138 AC: 21AN: 152234Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.0000395 AC: 9AN: 228106 AF XY: 0.0000325 show subpopulations
GnomAD4 exome AF: 0.0000165 AC: 24AN: 1454548Hom.: 0 Cov.: 85 AF XY: 0.0000138 AC XY: 10AN XY: 722868 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.000138 AC: 21AN: 152352Hom.: 0 Cov.: 33 AF XY: 0.000107 AC XY: 8AN XY: 74502 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Deficiency of steroid 11-beta-monooxygenase Pathogenic:2Uncertain:1
- -
ACMG:PVS1 PM2 PM3 -
This submission and the accompanying classification are no longer maintained by the submitter. For more information on current observations and classification, please contact variantquestions@myriad.com. -
not provided Uncertain:2
- -
This sequence change falls in intron 4 of the CYP11B1 gene. It does not directly change the encoded amino acid sequence of the CYP11B1 protein. It affects a nucleotide within the consensus splice site. This variant is present in population databases (rs193922542, gnomAD 0.05%). This variant has been observed in individual(s) with adrenal hyperplasia (PMID: 17371482). ClinVar contains an entry for this variant (Variation ID: 35991). Variants that disrupt the consensus splice site are a relatively common cause of aberrant splicing (PMID: 17576681, 9536098). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Deficiency of steroid 11-beta-monooxygenase;C3838731:Glucocorticoid-remediable aldosteronism Pathogenic:1
- -
CYP11B1-related disorder Pathogenic:1
The CYP11B1 c.799+5G>C variant is predicted to interfere with splicing. This variant was reported in the compound heterozygous state with a nonsense CYP11B1 variant in an individual with congenital adrenal hyperplasia due to 11-ß-hydroxylase deficiency (Andrew et al. 2007. PubMed ID: 17371482). This variant, along with a CYP11B1 nonsense variant, was also documented in an individual with congenital adrenal hyperplasia at PreventionGenetics (internal data). This variant is reported in 0.048% of alleles in individuals of African descent in gnomAD. This variant is interpreted as likely pathogenic. -
Congenital adrenal hyperplasia Uncertain:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at